Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.

Author: CameronAndrew, FenkelJonathan M, FrankAdam M, ShahAshesh P, SinghPooja

Paper Details 
Original Abstract of the Article :
We report here the successful treatment of hepatitis C virus (HCV) transmitted from a nucleic acid testing (NAT)-negative donor to three HCV-negative recipients-two renal transplants and one liver. Both renal recipients underwent standard deceased-donor renal transplantation with immediate graft fun...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/tid.12660

データ提供:米国国立医学図書館(NLM)

A Triumph Over Hepatitis C: Transplant Recipients Find Relief

The world of

transplantation

is a complex and challenging landscape, and managing potential complications is a critical aspect of patient care. This research highlights the successful treatment of donor-derived hepatitis C viral infection in three transplant recipients. The authors report a case series of three patients who received organs from a donor who was at increased risk for bloodborne pathogens. The recipients subsequently developed hepatitis C, but they were successfully treated with antiviral therapy. They found that [主要な発見] This research provides encouraging evidence for the successful management of donor-derived hepatitis C in transplant recipients.

Hope for Transplant Recipients

The study's findings offer a beacon of hope for transplant recipients who may be at risk for donor-derived hepatitis C. The successful treatment of these patients underscores the importance of early detection and effective antiviral therapy. This research highlights the advancements in hepatitis C treatment and the ability to manage this condition effectively, even in complex situations like organ transplantation.

Navigating the Desert of Transplantation

The desert of organ transplantation is vast and often unpredictable, with potential challenges and complications arising constantly. This research reminds us that advancements in medical treatment are constantly evolving, offering hope for managing complex conditions. By remaining vigilant, adapting to new treatments, and working collaboratively with patients, healthcare professionals can navigate the challenges of transplantation and improve outcomes for individuals receiving life-saving organs.

Dr.Camel's Conclusion

The journey of organ transplantation is often a complex and challenging one, but this research offers a testament to the power of medical advancements. The successful treatment of donor-derived hepatitis C in these transplant recipients underscores the importance of ongoing research and innovation in the field of transplantation. By embracing new therapies and adapting treatment approaches, we can move closer to a future where transplantation offers a greater chance of success for patients in need.

Date :
  1. Date Completed 2017-09-14
  2. Date Revised 2017-09-14
Further Info :

Pubmed ID

28060446

DOI: Digital Object Identifier

10.1111/tid.12660

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.